Piramal Enterprises Board Approves Raising Rs 3 000 Crore Through Ncds

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

Piramal Enterprises' board approves raising Rs 3,000 crore through NCDs

ri-calendar-2-lineAug 23, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

Piramal Enterprises Limited board approves to raise Rs 3,000 crore through non-convertible debentures.

 

The company said in an exchange filing on August 22 that the move will be carried out in one or more tranches, subject to regulatory approvals as needed.

 

The development comes only three weeks after Piramal disclosed a substantial drop in its pre-provisioning operating profit (PPOP) for the June 2023 quarter. The company stated that its PPOP was Rs 263 crore, a 58 percent decline year on year. Despite the reduction in PPOP, the company managed to increase its net profit by 24 percent.

 

Source: Media Reports

Related News

News Thumbnail
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

News Thumbnail
Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

News Thumbnail
Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

News Thumbnail
Company

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr

4 mins read. August 2, 2024 at 12:33 PM

Related Blogs

Stock chartIPO

CKK Retail Mart IPO Allotment Status Online

0 people read

5 mins read . Jan 30, 2026

Stock chartIPO

NFP Sampoorna Foods IPO Allotment Status Online

0 people read

4 mins read . Jan 30, 2026

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions